Skip to main content
Have a personal or library account? Click to login
Policy Considerations to Promote Equitable Cervical Cancer Screening and Treatment in Peru Cover

Policy Considerations to Promote Equitable Cervical Cancer Screening and Treatment in Peru

Open Access
|Nov 2021

References

  1. Zafra-Tanaka JH, Hurtado-Villanueva ME, Saenz-Naranjo M del P, Taype-Rondan A. Self-perceived competence in early diagnosis of cervical cancer among recently graduated physicians from Lima, Peru. PLoS ONE. 2018; 13(9). DOI: 10.1371/journal.pone.0203778
  2. Aguilar A, Pinto JA, Araujo J, et al. Control of cervical cancer in Peru: Current barriers and challenges for the future. Mol Clin Oncol. 2016; 5(2): 241245. DOI: 10.3892/mco.2016.926
  3. Piñeros M, Ramos W, Antoni S, et al. Cancer patterns, trends, and transitions in Peru: a regional perspective. Lancet Oncol. 2017; 18(10): e573e586. DOI: 10.1016/S1470-2045(17)30377-7
  4. Bruni L, Alberto G, Serrano B, et al. Human Papillomavirus and related diseases in Peru. Published online June 17, 2019. https://hpvcentre.net/statistics/reports/PER.pdf
  5. Paredes M, Thorp R. The persistence of horizontal inequalities and the role of policy: The case of Peru. Oxf Dev Stud. 2015; 43(1): 119. DOI: 10.1080/13600818.2014.975787
  6. Puyana A. Horizontal inequality and ethnic discrimination in four Latin American countries. CEPAL Rev. 2018; 125.
  7. Guía de práctica clínica para la prevención y manejo del cáncer de cuello uterino [Clinical practice guide for cervical cancer prevention and management]. Published online; 2017.
  8. Agurto I, Bishop A, Sánchez G, Betancourt Z, Robles S. Perceived barriers and benefits to cervical cancer screening in Latin America. Prev Med. 2004; 39(1): 91a98. DOI: 10.1016/j.ypmed.2004.03.040
  9. Olaza-Maguiña AF, De la Cruz-Ramirez YM. Barriers to the non-acceptance of cervical cancer screenings (pap smear test) in women of childbearing age in a rural area of Peru. Ecancermedicalscience. 2019; 13: 901. DOI: 10.3332/ecancer.2019.901
  10. Binagwaho A, Garcia PJ, Gueye B, et al. Eliminating deaths from cervical cancer—report of a panel at the 7th annual Symposium on Global Cancer Research, a satellite meeting at the Consortium of Universities for Global Health 10th Annual Meeting. J Glob Oncol. 2019; 5: 17. DOI: 10.1200/JGO.19.00287
  11. Paz-Soldán VA, Bayer AM, Nussbaum L, Cabrera L. Structural barriers to screening for and treatment of cervical cancer in Peru. Reprod Health Matters. 2012; 20(40). DOI: 10.1016/S0968-8080(12)40680-2
  12. Nevin PE, Garcia PJ, Blas MM, Rao D, Molina Y. Inequities in cervical cancer care in indigenous Peruvian women. Lancet Glob Health. 2019; 7(5): e556e557. DOI: 10.1016/S2214-109X(19)30044-0
  13. Aguilar A, Pinto JA, Araujo J, et al. Control of cervical cancer in Peru: Current barriers and challenges for the future. Mol Clin Oncol. 2016; 5(2): 241245. DOI: 10.3892/mco.2016.926
  14. Drolet M, Laprise J-F, Brotherton JML, et al. The impact of human papillomavirus catch-up vaccination in Australia: Implications for introduction of multiple age cohort vaccination and postvaccination data interpretation. J Infect Dis. 2017; 216(10): 12051209. DOI: 10.1093/infdis/jix476
  15. Garcia Zanabria JA, Sanchez Aguilar A, Hidalgo Calle N, et al. Perú: Enfermedades: No transmisibles y transmisibles, 2018. Published online May 2019.
  16. Barrionuevo-Rosas L, Palència L. ¿Cómo afecta el tipo de seguro de salud a la realización del Papanicolaou en Perú? Rev Panam Salud Publica. 2013; 8. Published online.
  17. Bartolini RM, Drake JK, Creed-Kanashiro HM, et al. Formative research to shape HPV vaccine introduction strategies in Peru. Salud Publica Mex. 2010; 52(3): 226233. DOI: 10.1590/S0036-36342010000300007
  18. Mendoza-Cervantes D, Otero I, Zujewski JA, et al. Building a network of health professionals for breast and cervical ancer control in the Andean region. J Glob Oncol. 2017; 4. DOI: 10.1200/JGO.2016.008714
  19. Torres-Roman JS, Ronceros-Cardenas L, Valcarcel B, et al. Cervical cancer mortality in Peru: regional trend analysis from 2008–2017. BMC Public Health. 2021; 21(1): 219. DOI: 10.1186/s12889-021-10274-1
  20. McClellan M, Thoumi A, Udayakumar K, Patel H, Samra ABA. Implementing accountable care to achieve better health at a lower cost. Published online 2016; 44.
  21. McClellan M, Udayakumar K, Thoumi A, et al. Improving care And lowering costs: Evidence and lessons from a global analysis of accountable care reforms. Health Aff (Millwood). 2017; 36(11): 19201927. DOI: 10.1377/hlthaff.2017.0535
  22. World Health Organization, World Health Organization, Reproductive Health and Research. Comprehensive cervical cancer control: a guide to essential practice. 2014. Accessed January 26, 2021. http://apps.who.int/iris/bitstream/10665/144785/1/9789241548953_eng.pdf?ua=1.
  23. World Health Organization. Primary health care systems: Case study from Peru, abridged version. Published online 2017.
  24. Ministerio de Salud. Documento tecnico: Plan Nacional de Prevencion y Control de Cancer de Cuello Uterino 2017–2021. Published online 2017.
  25. Decreto Supremo N 009-2012-SA. Published online 2012.
  26. OPS. Control integral del cáncer cervicouterino. Guía de prácticas esenciales. Published online 2016.
  27. McClellan M, Kent J, Beales SJ, et al. Accountable care around the world: A framework to guide reform strategies. Health Aff (Millwood). 2014; 33(9): 15071515. DOI: 10.1377/hlthaff.2014.0373
  28. Maru D, Maru S, Nirola I, et al. Accountable care reforms improve women’s and children’s health in Nepal. Health Aff Proj Hope. 2017; 36(11): 19651972. DOI: 10.1377/hlthaff.2017.0579
  29. Anticona Huaynate CF, Pajuelo Travezaño MJ, Correa M, et al. Diagnostics barriers and innovations in rural areas: insights from junior medical doctors on the frontlines of rural care in Peru. BMC Health Serv Res. 2015; 15. DOI: 10.1186/s12913-015-1114-7
  30. Jeronimo J, Morales O, Horna J, et al. Visual inspection with acetic acid for cervical cancer screening outside of low-resource settings. Rev Panam Salud Pública. 2005; 17(1). DOI: 10.1590/S1020-49892005000100001
  31. Luciani S, Munoz S, Gonzales M, Delgado JM, Valcarcel M. Effectiveness of cervical cancer screening using visual inspection with acetic acid in Peru. Int J Gynecol Obstet. 2011; 115(1): 5356. DOI: 10.1016/j.ijgo.2011.05.014
  32. Albújar-Baca P. El tamizaje citológico del cáncer cérvicouterino en la Región La Libertad, 2010. Published online 2013: 4.
  33. Almonte M, Ferreccio C, Luciani S, et al. Visual inspection after acetic acid (VIA) is highly heterogeneous in primary cervical screening in Amazonian Peru. PLoS ONE. 2015; 10(1). DOI: 10.1371/journal.pone.0115355
  34. Bayer AM, Nussbaum L, Cabrera L, Paz-Soldan VA. Missed opportunities for health education on Pap smears in Peru. Health Educ Behav Off Publ Soc Public Health Educ. 2011; 38(2): 198209. DOI: 10.1177/1090198110379580
  35. Ferris DG, Shapiro JM, Fowler CB, Cutler C, Waller J, Guevara Condorhuaman WSR. The impact of accessible cervical cancer screening in Peru—The Dia del Mercado Project. J Low Genit Tract Dis. 2015; 19(3): 229233. DOI: 10.1097/LGT.0000000000000112
  36. Morán F, Cárcamo C, Valderrama M, García PJ. Preferencias y satisfacción hacia un programa de tamizaje con pruebas autoadministradas de deteccion del virus de papiloma humano. Rev Peru Med Exp Salud Pública. 2017; 34(2): 228. DOI: 10.17843/rpmesp.2017.342.2453
  37. Dawson AJ, Buchan J, Duffield C, Homer CSE, Wijewardena K. Task shifting and sharing in maternal and reproductive health in low-income countries: a narrative synthesis of current evidence. Health Policy Plan. 2014; 29(3): 396408. DOI: 10.1093/heapol/czt026
  38. Johnson CM, Molina Y, Blas M, et al. “The disease is mine, the body is mine, I decide”: Individual, interpersonal, and institutional barriers and facilitators among survivors of women’s cancers in Andean countries. Health Care Women Int. 2018; 39(5): 522535. DOI: 10.1080/07399332.2017.1421198
  39. Ministerio de Salud. Resolucion Ministerial N 17-036512-002. Published online 2017.
  40. Gutiérrez-Aguado A. Costo-utilidad de la vacuna contra el virus de papiloma humano en mujeres peruanas. Rev Peru Med Exp Salud Publica. 2011; 28(3): 416425. DOI: 10.1590/S1726-46342011000300003
  41. Luque JS, Maupin JN, Ferris DG, Guevara Condorhuaman WS. Reaching women in the Peruvian Andes through cervical cancer screening campaigns: assessing attitudes of stakeholders and patients. Patient Prefer Adherence. 2016; 10: 2107. DOI: 10.2147/PPA.S119886
  42. Paul P, Winkler JL, Bartolini RM, et al. Screen-and-treat approach to cervical cancer prevention using visual inspection with acetic acid and cryotherapy: Experiences, perceptions, and beliefs from demonstration projects in Peru, Uganda, and Vietnam. The Oncologist. 2013; 18(S2): 612. DOI: 10.1634/theoncologist.18-S2-6
  43. Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, et al. Cost-effectiveness of cervical-cancer screening in five developing countries. N Engl J Med. 2005; 353(20): 21582168. DOI: 10.1056/NEJMsa044278
  44. Luciani S, Gonzales M, Munoz S, Jeronimo J, Robles S. Effectiveness of cryotherapy treatment for cervical intraepithelial neoplasia. Int J Gynecol Obstet. 2008; 101(2): 172177. DOI: 10.1016/j.ijgo.2007.11.013
  45. Mueller JL, Lam CT, Dahl D, et al. Portable Pocket colposcopy performs comparably to standard-of-care clinical colposcopy using acetic acid and Lugol’s iodine as contrast mediators—An investigational study in Perú. BJOG Int J Obstet Gynaecol. 2018; 125(10): 13211329. DOI: 10.1111/1471-0528.15326
  46. Mueller JL, Asma E, Lam CT, et al. International image concordance study to compare a point of care tampon colposcope to a standard-of-care colposcope. J Low Genit Tract Dis. 2017; 21(2): 112119. DOI: 10.1097/LGT.0000000000000306
  47. Colantonio L, Gómez JA, Demarteau N, Standaert B, Pichón-Rivière A, Augustovski F. Cost-effectiveness analysis of a cervical cancer vaccine in five Latin American countries. Vaccine. 2009; 27(40): 55195529. DOI: 10.1016/j.vaccine.2009.06.097
  48. World Health Organization, Alliance for Health Policy and Systems Research. Primary health care systems: Case study from Peru. Accessed July 21, 2020. https://www.who.int/alliance-hpsr/projects/alliancehpsr_peruabridgedprimasys.pdf?ua=1.
  49. de Habich M. Leadership politics and the evolution of the universal health insurance reform in Peru. Health Syst Reform. 2019; 5(3): 244249. DOI: 10.1080/23288604.2019.1635415
  50. Ponce de Leon Z. Healthcare reform out of nowhere? Policy reform and the lack of programmatic commitment in Peru. J Lat Am Stud. 2021; 53(3): 493519. DOI: 10.1017/S0022216X21000493
  51. Brophy Marcus M. When inequity, political instability, and culture meet COVID. Think Global Health. Published July 30, 2021. Accessed October 5, 2021. https://www.thinkglobalhealth.org/article/when-inequity-political-instability-and-culture-meet-covid.
  52. Canfell K, Kim JJ, Brisson M, et al. Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet Lond Engl. 2020; 395(10224): 591603. DOI: 10.1016/S0140-6736(20)30157-4
DOI: https://doi.org/10.5334/aogh.3442 | Journal eISSN: 2214-9996
Language: English
Published on: Nov 24, 2021
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2021 Andrea Thoumi, Sarah J. Bond, Mary Elizabeth Dotson, Marlee Krieger, Patricia J. Garcia, Nirmala Ramanujam, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.